Brief: Caladrius Biosciences Reports First Quarter 2022 Financial Results
05/05/2022 23:54
May 5 (Reuters) - Caladrius Biosciences Inc CLBS.O :
* CALADRIUS BIOSCIENCES REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* QTRLY BASIC AND DILUTED LOSS PER SHARE ATTRIBUTABLE $0.07
* Q1 EARNINGS PER SHARE VIEW $-0.10 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX2NS7hN
Further company coverage: CLBS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal